Clinical trial
Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme…
NCT00437463 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00437463 |
|---|---|
| Title | Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor |
| Official title | Treatment of Early Immunoglobulin A Nephropathy by ACE Inhibitor - a Randomized Controlled Trial |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Glomerulonephritis |
| Intervention type | Drug |
| Interventions | Ramipril |
| Enrollment | 60 |
| Start date | Jul 1, 2004 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Feb 21, 2007 |
| Last update posted | Nov 18, 2010 |
| Countries | Hong Kong |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: